Quinn Opportunity Partners LLC

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1633275 CHARLOTTESVILLE, VA

Position in BCRX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$674,016

New position

Shares Held

70,800

first reported quarter

Ownership

0.028%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 50% Shared 0% None 50%

Healthcare · as of Mar 31, 2026

Quinn Opportunity Partners LLC holds $5,525,801 across 4 Drug Manufacturers - Specialty & Generic names. BCRX ranks #4 (12.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRON	Cronos Group Inc.	969,033	$2,432,272
2	LFCR	Lifecore Biomedical, Inc. \De\	453,495	$1,687,001
3	VTRS	Viatris Inc	54,220	$732,512
4	BCRX	Biocryst Pharmaceuticals Inc This page	70,800	$674,016

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$674,016	70,800	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.